Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
ADC Therapeutics $105 million follow-on offering
We advised ADC Therapeutics on its offering of shares and pre-funded warrants
GXO Logistics $1.1 billion notes offering
The investment-grade notes are due 2029 and 2034
Svitzer Group demerger and Copenhagen listing
We advised A.P. Moller – Maersk and Svitzer Group on the demerger and commencement of trading in shares of Svitzer Group
Puig €2.6 billion IPO
Puig’s Class B shares are listed on the Spanish Stock Exchanges
CaixaBank $2 billion notes offering under $7.5 billion U.S. MTN program
The offering involved senior non-preferred callable fixed-to-floating-rate notes due 2030 and 2035
Avolta €500 million notes offering and cash tender offer
We advised Avolta on its high-yield notes offering and tender offer
Barratt Developments £2.52 billion all-share offer for Redrow
We are advising UBS as financial adviser and sponsor to Barratt Developments on the transaction
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
JPMorgan Chase €2 billion notes offering
We advised JPMorgan Chase on the euro notes offering